Korean J Cerebrovasc Dis.  2001 Mar;3(1):81-82.

A Case of Aplastic Anemia Associated with Ticlopidine

Affiliations
  • 1Department of Neurology, College of Medicine, The Catholic University of Korea, Seoul, Korea. KS1007@cmc.cuk.ac.kr

Abstract

Aplastic anemia is a rare side-effect associated with ticlopidine therapy. We report one case of severe aplastic anemia developed after the use of ticlopidine. A 72-year-old woman took ticlopidine at 500 mg/day to prevent a secondary stroke. Forty days after starting ticlopidine, she developed general weakness and nausea. She showed pancytopenia and was diagnosed as aplastic anemia, confirmed by bone marrow examination. Twelve days after the withdrwal of ticlopidine, the hematologic parameters improved. Physicians are reminded that complete blood cell counts and white blood cell count differentials should be monitored every 2 weeks in ticlopidine users during the first 3 months of treatment.

Keyword

Ticlopidine; Aplastic anemia

MeSH Terms

Aged
Anemia, Aplastic*
Blood Cell Count
Bone Marrow Examination
Female
Humans
Leukocyte Count
Nausea
Pancytopenia
Stroke
Ticlopidine*
Ticlopidine
Full Text Links
  • KJCD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr